Why is Max Healthcare falling/rising?

As of 02-Jul, Max Healthcare Institute Ltd is experiencing a price increase, currently at Rs 1,287.60, reflecting a rise of Rs 7.8 or 0.61%. The stock has shown strong performance recently, with a 1-week return of 3.99% and a 1-month return of 11.71%. It is also close to its 52-week high, being only 1.47% away from Rs 1,307.85. Despite a recent decline in investor participation, as indicated by a 51.74% drop in delivery volume, the stock has been gaining for the last two days, outperforming its sector by 1.46%. The company benefits from a low debt-to-equity ratio, healthy long-term growth in net sales and operating profit, and high institutional holdings, which contribute positively to its recent upward movement.
In the broader market context, Max Healthcare's short-term performance significantly outpaces the benchmark Sensex, which has only returned 0.79% over the past week. The stock's year-to-date return of 14.20% also exceeds the Sensex's 6.75%, indicating strong relative strength. Additionally, Max Healthcare's consistent returns over the past three years, along with its substantial market capitalization and sales figures, reinforce its position as a leader in the sector. This combination of factors suggests that the stock's recent rise is supported by both solid company fundamentals and favorable market conditions.